Clinical Trial Update: Evaluate the Safety and Efficacy of Calcitonin Gene-Related Peptide (CGRP) Antagonists in Patients With Dry Eye Disease and Asthenopia

View source ↗

Summary

A completed clinical trial evaluated the safety and efficacy of calcitonin gene-related peptide (CGRP) antagonists for dry eye disease and asthenopia.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Asthenopia
• Dry Eye Disease

Drugs mentioned

• CGRP antagonists

Snippet

Sponsor: Nvision Laser Eye Centers | Conditions: Dry Eye, Asthenopia | Status: COMPLETED